Systematic Review

Published on 24 Mar 2023

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Kefan Chen
Junhao He
Jing Xu
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1088741

2,428 views
5 citations

Review

Published on 24 Mar 2023

Diet-gut microbial interactions influence cancer immunotherapy

in Cancer Immunity and Immunotherapy

Xue Wang
Shitao Geng

Frontiers in Oncology

doi 10.3389/fonc.2023.1138362

3,304 views
8 citations

Original Research

Published on 24 Mar 2023

Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells

in Cancer Immunity and Immunotherapy

Marine Potez
Sebastian Snedal
Chunhua She
Jongmyung Kim
Konrad Thorner
Timothy H. Tran
Maria Cecilia Ramello
Daniel Abate-Daga
James K. C. Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1124272

5,797 views
2 citations

Original Research

Published on 23 Mar 2023

Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival

in Cancer Immunity and Immunotherapy

Zahra Mokhtari
Marzieh Rezaei
Mohammad Hossein Sanei
Amirreza Dehghanian
Zahra Faghih
Zahra Heidari
Shirin Tavana

Frontiers in Oncology

doi 10.3389/fonc.2023.1069696

2,453 views
9 citations

Original Research

Published on 22 Mar 2023

Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

in Cancer Immunity and Immunotherapy

Hui-xia Kang
Jun-ying Ma
Yan-yan Su
Shan Kang
Bao-jie Feng
Xiao-bei Feng
Xu-sha Wang
Yun-yun Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1120499

1,665 views

Original Research

Published on 21 Mar 2023

An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC

in Cancer Immunity and Immunotherapy

Guang Xia
Song Wu
Xiaoyu Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1161666

2,069 views

Original Research

Published on 17 Mar 2023

Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

in Cancer Immunity and Immunotherapy

Demis N. Lipe
Aiham Qdaisat
Patrick Chaftari
Monica K. Wattana
Pavitra P. Krishnamani
Cielito Reyes-Gibby
Sai-Ching J. Yeung

Frontiers in Oncology

doi 10.3389/fonc.2023.1122329

1,887 views
3 citations

Review

Published on 17 Mar 2023

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target

in Cancer Immunity and Immunotherapy

Zonglei Zhao
Xixiu Wang
Yan Ding
Xuefeng Cao
Xingyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1117642

3,806 views
3 citations

Review

Published on 17 Mar 2023

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?

in Cancer Immunity and Immunotherapy

Xiaoni Gao
Chengcheng Hong
Yang Xie
Xiangtai Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1103147

4,188 views
6 citations

Original Research

Published on 16 Mar 2023

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma

in Cancer Immunity and Immunotherapy

Hai Hu
Yuesong Yin
Binbin Jiang
Zhennan Feng
Ting Cai
Song Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1156455

3,840 views
5 citations

Original Research

Published on 16 Mar 2023

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response

in Cancer Immunity and Immunotherapy

Bomiao Zhang
Yien Li
Liqiang Song
Hua Xi
Shaoke Wang
Chenfeng Yu
Binbin Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1061084

2,364 views
3 citations

Case Report

Published on 14 Mar 2023

Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after interstitial pneumonia

in Cancer Immunity and Immunotherapy

Luo Wang
Haibo Mou
Xuehua Hou
Qin Liao

Frontiers in Oncology

doi 10.3389/fonc.2023.1126769

2,313 views
2 citations

Editorial

Published on 13 Mar 2023

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors

in Cancer Immunity and Immunotherapy

Chunrun Qu
Longbo Zhang
Wen Cheng
Quan Cheng
Junxia Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1147883

1,360 views

Review

Published on 09 Mar 2023

Immune cells and immune cell-targeted therapy in chronic pancreatitis

in Cancer Immunity and Immunotherapy

Yu Zhang
Wen-Qing Zhang
Xin-Yuan Liu
Qi Zhang
Tao Mao
Xiao-Yu Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1151103

3,407 views
6 citations

Original Research

Published on 03 Mar 2023

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid

in Cancer Immunity and Immunotherapy

Jianglin Wang
Xin Hu
Wei Jiang
Wenjie Zhou
Mengjie Tang
Cuifang Wu
Wei Liu
Xiaocong Zuo

Frontiers in Oncology

doi 10.3389/fonc.2023.1095694

4,260 views
5 citations

Original Research

Published on 03 Mar 2023

Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Tianshu Xie
Yi Wei
Lifeng Xu
Qian Li
Feng Che
Qing Xu
Xuan Cheng
Minghui Liu
Meiyi Yang
Xiaomin Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1103521

2,897 views
8 citations

Navigation group

Articles

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

Diet-gut microbial interactions influence cancer immunotherapy

Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells

Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival

Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC

Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response

Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after interstitial pneumonia

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors

Immune cells and immune cell-targeted therapy in chronic pancreatitis

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid

Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma